06 Nov MYC Inhibition Reprograms Tumor Immunity and Enhances Immunotherapy Efficacy in KRAS Mutant NSCLC

ID: 03233

Authors: Casacuberta-Serra, Sílvia (1); González-Larreategui, Íñigo (2); Vera, Laura (3); Adradas, Vera (6); Martínez-Martín, Sandra (1); López-Estévez, Sergio (1); Arnal Segura, Magdalena (1); Sansegundo, Lorena (1); Capitán-Leo, Daniel (2); Serrano, Erika (2); Grueso, Judit (1,2); Foradada, Laia (1); Thabussot, Hugo (1); Giuntini, Fabio (2); R. Whitfield, Jonathan (2); Beaulieu, Marie-Eve (1); Vicent, Silvestre (3,4,5); Zugazagoitia, Jon (4,6,7,8); Soucek, Laura (1,2,9,10)

Topic: INNOVATIVE THERAPIES